Enrichment of functional CD8 memory T cells specific for MUC1 in bone marrow of patients with multiple myeloma
Authors:
- 1 March 2005
- journal article
- Published by American Society of Hematology in Blood
- Vol. 105 (5) , 2132-2134
Abstract
Multiple myeloma (MM) is one of the most common hematologic malignancies. Despite extensive therapeutical approaches, cures remain rare exceptions. An important issue for future immunologic treatments is the characterization of appropriate tumor-associated antigens. Recently, a highly glycosylated mucin MUC1 was detected on a majority of multiple myeloma cell lines. We analyzed bone marrow and peripheral blood of 68 patients with HLA-A2–positive myeloma for the presence and functional activity of CD8 T cells specific for the MUC1-derived peptide LLLLTVLTV. Forty-four percent of the patients with MM contained elevated frequencies of MUC1-specific CD8 T cells in freshly isolated samples from peripheral blood (PB) or bone marrow (BM) compared with corresponding samples from healthy donors. BM-residing T cells possessed a higher functional capacity upon specific reactivation than PB-derived T cells with regard to interferon γ (IFN-γ) secretion, perforin production, and cytotoxicity.Keywords
This publication has 20 references indexed in Scilit:
- Vigorous Premalignancy-specific Effector T Cell Response in the Bone Marrow of Patients with Monoclonal GammopathyJournal of Experimental Medicine, 2003
- Bone marrow as a priming site for T-cell responses to blood-borne antigenNature Medicine, 2003
- T-cell epitopes within the complementarity-determining and framework regions of the tumor-derived immunoglobulin heavy chain in multiple myelomaBlood, 2003
- High-dose therapy and immunomodulatory drugs in multiple myelomaSeminars in Oncology, 2002
- Cognate interactions between memory T cells and tumor antigen‐presenting dendritic cells from bone marrow of breast cancer patients: Bidirectional cell stimulation, survival and antitumor activity in vivoInternational Journal of Cancer, 2002
- Survival in conventionally treated younger (<60 years) multiple myeloma patients: no improvement during two decadesEuropean Journal of Haematology, 1999
- The prognostic significance of T cell receptor β gene rearrangements and idiotype-reactive T cells in multiple myelomaLeukemia, 1997
- MUC‐1 Epithelial Tumor Mucin‐Based Immunity and Cancer VaccinesImmunological Reviews, 1995
- Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1.Journal of Experimental Medicine, 1994
- Persistence of dormant tumor cells in the bone marrow of tumor cell-vaccinated mice correlates with long-term immunological protection.Proceedings of the National Academy of Sciences, 1994